Severe acute respiratory syndrome coronavirus 2 and influenza A virus co-infection in a nine-year-old boy from a family cluster – case report

In this case report we present a nine-year-old boy from a family cluster with SARS-CoV-2 and influenza virus co-infection. He presented with the most common manifestations of COVID-19 reported in paediatric population – fever and cough. Severe acute respiratory syndrome coronavirus 2 infection was diagnosed by RT-PCR assay, and influenza type A by rapid immunochromatic assay testing. The course of disease was mild, despite co-infection with two viruses. In the time of COVID-19 pandemic testing for influenza, respiratory syncytial virus (RSV), and SARS-CoV-2 in suspected cases is essential for establishing a diagnosis, and it has important implications for patient management.

REFERENCES (13)

World Health Organization. Coronavirus disease (COVID-19) pandemic. https://www.who.int/emergencie... (access: 26 May 2020).

Google Scholar

Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Coronavirus COVID-19 global cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Published 2020. https://coronavirus.jhu.edu/ map.html (access: 24 April 2020).

Google Scholar

Dong Y, Mo X, Hu Y, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics 2020; 145: e20200702.

Google Scholar

Rasmussen SA, Thompson LA. Coronavirus Disease 2019 and Children. What Pediatric Health Care Clinicians Need to Know. JAMA Pediatr 2020; 174: 743-744.

Google Scholar

Zimmermann P, Curtis N. Coronavirus Infection in Children Including COVID-19, an overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children. Pediatr Infect Dis J 2020; 39: 355-368.

Google Scholar

Hoang A, Chorath K, Moreira A, et al. COVID-19 in 7780 pediatric patients: A systematic review, EClinicalMedicine 2020; 24: 100433.

Google Scholar

McCreary E, Pogue J. Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options. Open Forum Infect Dis 2020; 7: ofaa105.

Google Scholar

Tan EL, Ooi EE, Lin CY, et al. Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs. Emerg Infect Dis 2004; 10: 581-586.

Google Scholar

Bacharier LB, TW Guilbert TW, Mauger DT, et al. Early administration of azithromycin and prevention of severe lower respiratory tract illnesses in preschool children with a history of such illnesses: A randomized clinical trial. JAMA 2015; 314: 2034-2044.

Google Scholar

10.

Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020; 56: 105949.

Google Scholar

11.

Wehl G, Laible M, Rauchenzauner M. Co-infection of SARS CoV2 and influenza A in a Pediatric Patient in Germany. Klin Padiatr 2020; 232: 217-218.

Google Scholar

12.

Wu X, Cai Y, Huang X, et al. Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China. Emerg Infect Dis 2020; 26: 1324-1326.

Google Scholar

13.

Wu D, Lu J, Ma X, et al. Coinfection of Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2). Pediatr Infect Dis J 2020; 39: e79.

Google Scholar

SUBMIT YOUR PAPER